Publications Office of the EU
Tisagenlecleucel (Kymriah) in paediatric patients or adolescents up to 25 years of age with time-lapse - EU tenders
DisplayCustomHeader
MyPortal
Language Selector
English
BasketSummary
Procurement Detail Actions Portlet

Utilities

Procurement Detail Actions Portlet
OP Portal - Procurement - Details

This page contains content generated automatically to improve findability and accessibility

- indicates CPV codes deduced from the text of the procedure

- indicates text translated automatically in your browsing language

Tisagenlecleucel (Kymriah) in paediatric patients or adolescents up to 25 years of age with time-lapse Text automatically translated in your browsing language Automatically translated

Overview
  • Awarded
    28/01/2025
  • Today
    01/07/2025
Status
Awarded
Type of contract
Supplies
Subject for Renewal
Yes
Buyer
HUS Group, the joint authority for Helsinki and Uusimaa
Place of performance
NUTS code: Multiple place of performance
Location of buyer
NUTS code: FI1B1 Helsinki-Uusimaa
Business sector (Main CPV)
33600000 Pharmaceutical products
Total estimated contract value (excluding VAT)
Not available
Total final contract value (excluding VAT)
9,000,000.00 EUR
Procedure details
Tender reference number
Not available
Description

Tisagenlecleucel (Kymriah 1.2x10e6-6x10e8 cells solution for infusion) for use in paediatric patients and adolescent adult patients up to 25 years of age with B-cell line acute lymphoblastic leukaemia (ALL) who have not responded to previous treatment (treatment-resistant), who have relapsed twice or more, or who have relapsed after stem cell transplantation, as recommended by the Council on Healthcare Choices (Ealko) (13 March 2019). Text automatically translated in your browsing language Automatically translated

Submission Method
Not available
Tenders may be submitted
Not available
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
Not available
Buyers
Pirkanmaan hyvinvointialue
Pohjois-Pohjanmaan hyvinvointialue
Pohjois-Pohjanmaan hyvinvointialue
Varsinais-Suomen hyvinvointialue
Pirkanmaan hyvinvointialue
Varsinais-Suomen hyvinvointialue
Place of performance
FI Suomi/Finland
Any country
CPV code

33600000 - Pharmaceutical products

60000000 - Transport services (excl. Waste transport) CVP code deduced from the text of the procedure AI-generated

33100000 - Medical equipments CVP code deduced from the text of the procedure AI-generated

Award method
Criterion:
Type: price
Description: Kiinteä hinta yksikköä kohti.
Weight (percentage, exact): 100
Estimated value
Not available
Final contracted value
9,000,000.00 EUR
Award of contract
Official name: Novartis Finland Oy
Postal address:
Town: Espoo
Postal code: 02130
Country:
Documents
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.